Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis.
Lantern Pharma stock last closed at $2.34, up 2.18% from the previous day, and has decreased 44.15% in one year. It has underperformed other stocks in the Biotechnology industry by 0.29 percentage points. Lantern Pharma stock is currently +110.81% from its 52-week low of $1.11, and -50.24% from its 52-week high of $4.70.
At the moment, there are 12.78M shares of LTRN outstanding. The market value of LTRN is $29.91M. In the past 24 hours, 185,000 LTRN shares were traded.
You will need a brokerage account to access the NASDAQ market and buy LTRN shares.
Based on our analysis, eToro is the best online stock brokerage. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal information so you can buy LTRN today.
Now that you have created your account on the best stock trading app for beginners, you need to deposit funds:
Check out the tutorial below if you need help depositing money into your new investment account.
After you have chosen the best place to buy Lantern Pharma stock, it's very important to evaluate their stock prior to investing, so you truly comprehend the risk as well as the upside.
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can see all of the due diligence checks on LTRN's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge LTRN's fair value.
You can access additional valuation research on LTRN's stock here.
You can dive deeper into what analysts are saying on the Lantern Pharma stock forecast page.
In the last year, executives and large shareholders at LTRN have bought more shares than they have sold.
D. Jeffrey Keyser, Director of LTRN, was the latest LTRN insider to buy. They bought $100,000.64 worth of LTRN stock on May 12, 2026.
Get more info about who owns LTRN stock here.
No, Lantern Pharma doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two primary types of orders:
Press the Open button and eToro will place the order.
If you need more help buying stocks on eToro, watch the helpful video below:
Now that you own some shares in LTRN, you'll want to keep up with your company.
Put LTRN on a watchlist to get notified of the latest news about your LTRN stock.
To summarize, here are the 6 steps to buy Lantern Pharma stock:
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your new investment in Lantern Pharma, create a watchlist on WallStreetZen today.